Pharmaceutical Companies Accelerate Drug Development Using Artificial Intelligence
Pharmaceutical companies are increasingly integrating artificial intelligence (AI) into drug development processes, including discovery, laboratory automation, clinical trials, and regulatory reviews. Leading firms such as Novo Nordisk, Sanofi, Dr Reddy's, Eli Lilly, Pfizer, and AstraZeneca are investing heavily in AI partnerships and proprietary technologies. While AI has significantly reduced drug discovery times, challenges remain in clinical trial phases, which continue to be costly and time-consuming.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 42/100.
Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 27 Oct, 05:41 am. Other outlets followed.